Serum levels of monocyte chemoattractant protein (MCP)‐1 and circulating C‐reactive protein (CRP) have been also shown to persist at high levels in stroke patients at the 3‐month follow‐up compared to baseline (Garlichs et al, 2003; Ladenvall et al, 2006). Here, CRP is linked to stroke disorder.